$32.37
+1.99 (+6.55%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-12.94%
1Y
+30.21%
YTD
-8.61%
Open$30.52
Previous Close$30.38
Day High$32.90
Day Low$30.52
52W High$43.15
52W Low$22.96
Volume—
Avg Volume2.15M
Market Cap3.53B
P/E Ratio—
EPS$-4.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$32.83
Below
SMA 200
$31.34
Above
RSI (14)
52.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
+110.7% upside
Current
$32.37
$32.37
Target
$68.21
$68.21
$46.84
$68.21 avg
$80.11
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.82B | 1.78B | 1.68B |
| Net Income | 202.06M | 220.26M | 147.13M |
| Profit Margin | 11.1% | 12.3% | 8.7% |
| EBITDA | 246.26M | 251.94M | 230.42M |
| Free Cash Flow | 210.43M | 219.41M | 153.78M |
| Rev Growth | +17.6% | -0.7% | +11.4% |
| Debt/Equity | 0.22 | 0.23 | 0.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |